The flavonoid morin restores blood pressure and lipid metabolism in DOCA-salt hypertensive rats

Redox Report

Volumn 17, Issue 4, 2012, Pages 167-175

  Prahalathan, Pichavaram ^a   Saravanakumar, Murugesan ^a   Raja, Boobalan ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Collagen; Dyslipidemia; Reactive oxygen species; Uninephrectomy

Indexed keywords

DEOXYCORTICOSTERONE ACETATE; DRINKING WATER; FLAVONOID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; MORIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; REACTIVE OXYGEN METABOLITE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE SEVERITY; DYSLIPIDEMIA; ENZYME ACTIVITY; HEART RATE; HISTOPATHOLOGY; HYPERTENSION; LIPID METABOLISM; LIVER; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; UNINEPHRECTOMY;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY WEIGHT; CHOLESTEROL; DESOXYCORTICOSTERONE; DRUG EVALUATION, PRECLINICAL; FLAVONOIDS; HEART RATE; HYDROXYMETHYLGLUTARYL COA REDUCTASES; HYPERLIPIDEMIAS; HYPERTENSION; HYPOLIPIDEMIC AGENTS; KIDNEY; LIPID METABOLISM; LIVER; MALE; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE; PHYTOTHERAPY; RATS; RATS, WISTAR; SODIUM CHLORIDE;

RATTUS;

EID: 84866936180     PISSN: 13510002     EISSN: 17432928     Source Type: Journal    
DOI: 10.1179/1351000212Y.0000000015     Document Type: Article

References (40)

1. World Health Organization. Available from http://www.who.int/mediacentre/factsheets/fs317/en/ [accessed 31 January 2011].
2. Chapman MJ, Sposito AC. Hypertension and dyslipidemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy. Pharmacol Ther 2008; 117:354-73.
3. Wong ND, Lopez V, Tang S, Williams GR. Prevalence, treatment, and control of combined hypertension and hypercholesterolemia in the United States. Am J Cardiol 2006;98:204-8.
4. Kwon HM, Sangiorgi G, Ritman EL. Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J Clinic Invest 1998;101:1551-6.
5. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, treatment of high blood pressure. Hypertens 2003;42:1206-52.
6. Jagla A, Schrezenmeir J. Postprandial triglycerides and endothelial function. Exp Clin Endocrinol Diabetes 2001;109:533-47.
7. Palmieri VO, Grattagliano I, Portincasa P. Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome. J Nutr 2006;136:3022-6.
8. Harborne JB, Williams CA. Advances in flavonoid research since 1992. Phytochemistry 2000;55:481-504.
9. Hou YC, Chao PDL, Ho HJ. Profound difference in pharmacokinetics between morin and its isomer quercetin in rats. J Pharm Pharmacol 2003;55:199-203.
10. Retelny VS, Neuendorf A, Roth JL. Nutrition protocols for the prevention of cardiovascular disease. Nutr Clin Pract 2008;23: 468-76.
11. Rattanachaikunsopon P, Phumkhachorn P. Contents and antibacterial activity of flavonoids extracted from leaves of Psidium quajava. J Med Plants Res 2010;4:393-6.
12. Lotito SB, Frei B. Consumption of flavonoid rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon. Free Radic Biol Med 2006;41: 1727-46.
13. Subash S, Subramanian P. Morin a flavonoid exerts antioxidant potential in chronic hyperammonemic rats: a biochemical and histopathological study. Mol Cell Biochem 2009;32:153-61.
14. Francis AR, Shetty TK, Bhattacharya RK. Modifying role of dietary factors on the mutagenicity of aflatoxin B1: in vitro effect of plant flavonoids. Mutat Res 1989;222:393-401.
15. Sivaramakrishnan V, Shilpa P, Kumar V, Niranjali Devaraj S. Attenuation of N-nitrosodiethylamine-induced hepatocellular carcinogenesis by a novel favonol-morin. Chem Biol Inter 2008;171:79-88.
16. Sivaramakrishnan V, Devaraj SN. Morin regulates the expression of NF-kB-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma. Chem Biol Inter 2009;180:353-9.
17. Prahalathan P, Kumar S, Raja B. Effect of morin, a flavonoid against DOCA-salt hypertensive rats: a dose dependent study. Asian Pac J Trop Biomed 2012;2:443-8.
18. Prahalathan P, Kumar S, Raja B. Morin attenuates blood pressure and oxidative stress in deoxycorticosterone acetate -salt hypertensive rats: a biochemical and histopathological evaluation. Metabolism 2012; doi:10.1016/j.metabol.2011.12.012 (In press).
19. Abishek I, Andrew F, Junxian L, Giang T, Robert C, Maria A. Antifibrotic activity of an inhibitor of histone deacetylases in DOCA-salt hypertensive rats. Brit J Pharmacol 2010;159:1408-17.
20. Vincent C, Andrew F, Abishek I, Andrew H, Lindsay B. Resveratrol improves cardiovascular function in DOCA-salt hypertensive rats. Curr Pharm Biotechnol 2011;12:429-36.
21. Karthik Kumar V, Vennila S, Nalini N. Inhibitory effect of morin on DMH-induced biochemical changes and aberrant crypt foci formation in experimental colon carcinogenesis. Environ Toxicol Phar 2010;29:50-7.
22. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
23. Folch J, Lees M, Sloane SGH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957;226:497-509.
24. Zlatkis A, Zak B, Boyle AJ. A new method for the direct determination of serum cholesterol. J Lab Clin Med 1953;41: 486-92.
25. Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982;28:2077-80.
26. Falholt K, Lund B, Falholt W. An easy colorimetric micromethod for routine determination of free fatty acids in plasma. Clin Chim Acta 1973;46:105-1.
27. Zilversmit DB, Davis AK. Microdetermination of plasma phospholipids by trichloroacetic acid precipitation. J Lab Clin Med 1950;35:155-60.
28. Philipp B, Shapiro DJ. Improved methods for the assay and activation of 3-hydroxy-3-methyl glutaryl coenzyme A reductase. J Lipid Res 1970;20:588-93.
29. Hitz J, Steinmetz G Siest. Plasma lecithin: cholesterol acyltransferasereference values and effects of xenobiotics. Clin Chim Acta 1983;133:85-96.
30. Sesso HD, Gaziano JM, Liu S, Buring JE. Flavonoid intake and the risk of cardiovascular disease in women. Am J Clin Nutr 2003;77:1400-8.
31. Rosario J, Rocio Lopez S, Maria K. Polyphenols restore endothelial function in DOCA-salt hypertension: role of endothelin-1 and NADPH oxidase. Free Radic Biol Med 2007;43:462-73.
32. Friedwald WT, Levy RJ, Fredricken DS. Estimation of the concentration of LDL-cholesterol in the plasma without the use of preparative ultracentrifuge. Clin Chem 1972;18:499-502.
33. Salter AM, White DA. Effects of dietary fat on cholesterol metabolism: regulation of plasma LDL concentrations. Nutr Res 1996;9:241-57.
34. McKenney JM. Pharmacotherapy of dyslipidemia. Cardiovasc Drugs Ther 2001;15:413-22.
35. Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 1998;81:7-12.
36. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993;91:2546-51.
37. Goldstein JL, Brown MS. Progress in understanding the LDL receptor and HMG-CoA reductase, two membrane proteins that regulate the plasma cholesterol. J Lipid Res 1984;25: 1450-61.
38. Miller NE, Thelle DS, Forde OH. The Tromso heart-study. HDL and coronary heart-disease: a prospective case controlstudy. Lancet 1977;1:965-8.
39. Easterbauer H, Gebick J, Phal H. The role of lipidperoxidation and antioxidants in the oxidative modifications of LDL. Free Radic Biol Med 1992;13:341-90.
40. Kok DL, Wong YP, Wu TW, Chan HC, Kwok TT, Fung KP. Morin hydrate a potential antioxidant in minimizing the free radicals-mediated damage to cardiovascular cells by anti-tumor drug. Life Sci 2000;67:91-9.